ALDH7A1 and Huntington disease: Due to its key roles in synaptic plasticity, axonal transport of neurotrophic receptors, and intracellular signaling, the modulation of intracellular cyclic AMP by analogs or PDE inhibitors has become an attractive target for HD therapeutics [31].